Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for WUCT aggregates regulatory documents tied to ETRACS Whitney US Critical Technologies ETNs issued by UBS AG, a foreign private issuer. The core filings here are Forms 6-K, which provide interim financial and legal updates that are incorporated by reference into UBS AG’s Form F-3 registration statement for securities offerings.
In these Form 6-K reports, UBS AG discloses consolidated capitalization in US dollars under IFRS Accounting Standards, detailing short-term and long-term debt issued by UBS AG and its subsidiaries, funding from UBS Group AG, equity attributable to shareholders and non-controlling interests, and total capitalization. Such information helps investors understand the broader balance sheet context of the issuer behind the WUCT-linked ETNs.
The filings also explain how specific 6-K reports are incorporated into UBS AG’s Form F-3 registration statement and any outstanding prospectuses or offering circulars that reference those 6-Ks. This structure means that updates filed on Form 6-K become part of the official documentation for securities, including the ETRACS Whitney US Critical Technologies ETNs associated with WUCT.
Another Form 6-K on this page consists of the opinion of Homburger AG, acting as special Swiss counsel to UBS AG, which is filed as an exhibit to the Form F-3 registration statement and replaces a prior opinion. This highlights the role of legal opinions in UBS AG’s securities registration process.
On Stock Titan, users can access these filings in one place, with AI-powered tools available to summarize key sections, highlight important capitalization and legal disclosures, and help interpret how each new Form 6-K or related document fits into UBS AG’s overall reporting framework for the WUCT-linked ETNs.
UBS AG London Branch plans to issue Contingent Income Auto-Callable Securities maturing on or about 30 June 2028 that are linked to the common stock of Meta Platforms, Inc. (META). Each security has a $1,000 stated principal amount and is expected to price on 27 June 2025 and settle on 2 July 2025. Holders may receive quarterly contingent coupons of $27.00 (10.80% p.a.) provided META’s closing price on the relevant observation date is at or above the 60% downside threshold. If on any quarterly determination date (other than the final one) META closes at or above the 100% call threshold, the notes are automatically redeemed at par plus the coupon.
At maturity, investors receive: (i) par plus the final coupon if META is at or above the downside threshold; or (ii) a cash value equal to META’s final price multiplied by the exchange ratio if the downside threshold is breached, exposing investors to losses of up to 100% of principal. The securities do not participate in any upside above par, are unsecured, unsubordinated obligations of UBS and will not be listed on any exchange. Estimated initial value is expected between $934.70 and $964.70, reflecting embedded fees (2.25% selling concession) and dealer margins.
The preliminary prospectus highlights multiple risks: credit exposure to UBS, limited or no secondary market, potential early redemption, price volatility of a single equity, and uncertain U.S. tax treatment. Investors should review the complete risk factors in the preliminary pricing supplement before purchasing.